BR112017026013A2 - sistema de distribuição oral, alginato de etilenodiamônio, grânulos de alginato de etilenodiamônio e alimentação funcional - Google Patents

sistema de distribuição oral, alginato de etilenodiamônio, grânulos de alginato de etilenodiamônio e alimentação funcional

Info

Publication number
BR112017026013A2
BR112017026013A2 BR112017026013A BR112017026013A BR112017026013A2 BR 112017026013 A2 BR112017026013 A2 BR 112017026013A2 BR 112017026013 A BR112017026013 A BR 112017026013A BR 112017026013 A BR112017026013 A BR 112017026013A BR 112017026013 A2 BR112017026013 A2 BR 112017026013A2
Authority
BR
Brazil
Prior art keywords
ethylenediamonium
alginate
delivery system
oral delivery
granules
Prior art date
Application number
BR112017026013A
Other languages
English (en)
Other versions
BR112017026013B1 (pt
Inventor
Klaric Goran
Wadsworth Simon
Nalin Jayasingh Suwan
Original Assignee
Ewos Innovation As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO20150715A external-priority patent/NO344096B1/en
Priority claimed from GB1509608.4A external-priority patent/GB2539006A/en
Application filed by Ewos Innovation As filed Critical Ewos Innovation As
Publication of BR112017026013A2 publication Critical patent/BR112017026013A2/pt
Publication of BR112017026013B1 publication Critical patent/BR112017026013B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/163Sugars; Polysaccharides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K40/00Shaping or working-up of animal feeding-stuffs
    • A23K40/30Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/80Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)

Abstract

a presente invenção refere-se a uma alimentação funcional e a um sistema de distribuição oral para administração de macromoléculas bioativas. o sistema de distribuição oral compreende alginato de etilenodiamônio que é um veículo para distribuição de drogas macromoleculares. o sistema de distribuição oral, de acordo com a presente invenção, é particularmente adequado para utilização em combinação com alimentos funcionais em peixes.
BR112017026013-1A 2015-06-03 2016-06-02 Sistema de distribuição oral de agentes bioativos e alimentação funcional para administração oral de agentes bioativos BR112017026013B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NO20150715A NO344096B1 (en) 2015-06-03 2015-06-03 Oral delivery system for bioactive active agents
GB1509608.4 2015-06-03
NO20150715 2015-06-03
GB1509608.4A GB2539006A (en) 2015-06-03 2015-06-03 Functional feed
PCT/NO2016/050113 WO2016195509A1 (en) 2015-06-03 2016-06-02 Oral delivery system for bioactive agents

Publications (2)

Publication Number Publication Date
BR112017026013A2 true BR112017026013A2 (pt) 2018-08-14
BR112017026013B1 BR112017026013B1 (pt) 2023-12-05

Family

ID=56360457

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017026013-1A BR112017026013B1 (pt) 2015-06-03 2016-06-02 Sistema de distribuição oral de agentes bioativos e alimentação funcional para administração oral de agentes bioativos

Country Status (9)

Country Link
US (2) US20180147147A1 (pt)
EP (2) EP3302445A1 (pt)
CN (1) CN108076627B (pt)
BR (1) BR112017026013B1 (pt)
CA (1) CA2987932C (pt)
CL (1) CL2017003077A1 (pt)
EC (1) ECSP18000069A (pt)
MX (1) MX2017015545A (pt)
WO (1) WO2016195509A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102018126394B4 (de) * 2018-10-23 2020-12-24 Universität Rostock Probiotika enthaltendes Depotsystem für dentale Anwendungen
KR20230171094A (ko) * 2022-06-13 2023-12-20 부산대학교 산학협력단 산성 환경에서 프로바이오틱스를 보호하는 하이드록시아파타이트-하이드로겔 복합체 및 이를 포함하는 프로바이오틱스 전달용 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935250A (en) * 1984-05-01 1990-06-19 Inverness Management Corporation Coated fish feed pellets
GB2270920B (en) * 1992-09-25 1997-04-02 Univ Keele Alginate-bioactive agent conjugates
DE69530553T2 (de) * 1994-05-13 2004-03-25 KURARAY CO., LTD, Kurashiki Medizinisches polymergel
SE9401738D0 (sv) * 1994-05-19 1994-05-19 Ewos Ab Bioactive feed
FR2799196B1 (fr) * 1999-10-04 2002-02-08 Sod Conseils Rech Applic Copolymeres reticules a base de copolymeres polycarboxyliques non reticules
JP4565691B2 (ja) * 2000-02-28 2010-10-20 株式会社Phg ヘパリン結合性成長因子用徐放基材、およびヘパリン結合性成長因子徐放剤
SE0103613D0 (sv) * 2001-10-30 2001-10-30 Astrazeneca Ab Novel formulation
NO320671B1 (no) * 2001-11-30 2006-01-16 Fmc Biopolymer As Fremgangsmate for a stimulere vektokning i fisk.
NZ539900A (en) * 2002-11-07 2008-03-28 Advanced Bionutrition Corp Nutraceuticals and method of feeding aquatic animals
CN1268346C (zh) * 2003-11-19 2006-08-09 上海中科伍佰豪生物工程有限公司 生物多糖微胶囊及其制备方法和用途
WO2005115341A2 (en) * 2004-05-27 2005-12-08 Advanced Bionutrition Corporation Microparticles for oral delivery
ITMI20052461A1 (it) * 2005-12-22 2007-06-23 Univ Degli Studi Milano Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
CN101549158A (zh) 2009-05-08 2009-10-07 南开大学 一种海藻酸钠肝靶向纳米给药系统及其制备方法
WO2012016282A1 (en) 2010-08-03 2012-02-09 Jorrocks Pty Ltd. Vacuum infusion for the inclusion of a supplement into food products
UA103834C2 (ru) * 2012-06-15 2013-11-25 Павел Петрович Пивоваров Капсулированный белоксодержащий продукт и способ его получения
CN103627010A (zh) * 2013-11-18 2014-03-12 戴建英 一种海藻酸酰胺类医用敷料的制备方法

Also Published As

Publication number Publication date
CL2017003077A1 (es) 2019-07-19
EP3881835A1 (en) 2021-09-22
EP3302445A1 (en) 2018-04-11
CA2987932A1 (en) 2016-12-08
BR112017026013B1 (pt) 2023-12-05
WO2016195509A1 (en) 2016-12-08
US20220409541A1 (en) 2022-12-29
CN108076627A (zh) 2018-05-25
US20180147147A1 (en) 2018-05-31
US11844863B2 (en) 2023-12-19
MX2017015545A (es) 2018-11-09
CA2987932C (en) 2024-01-16
CN108076627B (zh) 2021-05-25
ECSP18000069A (es) 2018-10-31

Similar Documents

Publication Publication Date Title
CL2015003545A1 (es) Una capsula para preparar composiciones comestibles
BR112018010671A8 (pt) dispositivos e métodos de distribuição de fármaco com mudança de forma
EP3558420A4 (en) DRUG DELIVERY DEVICE AND METHODS OF DELIVERY OF DRUGS TO INFANTS AND CHILDREN
EP3445416A4 (en) ENTERALES ACTIVE COMPOSITION SYSTEM
BR112017003346A2 (pt) derivados de pirazolopiridina, seus usos, e composição farmacêutica
BR112017026241A2 (pt) composições farmacêuticas e alimentícias para induzir a saciação e prolongar a saciedade em indivíduos que necessitem das mesmas
BR112015023523B8 (pt) Composições farmacêuticas e recipiente de forma de dosagem única
EA201700019A1 (ru) Высокочистый оритаванцин и способ его получения
EP3554435A4 (en) SYSTEMS AND METHODS FOR DELIVERY OF MEDICINAL PRODUCTS TO RETINAL TISSUE
BR112017022846A2 (pt) combinação de dose fixa inviolável que proporciona rápida liberação de dois fármacos de partículas diferentes
BR112017006779A2 (pt) composição farmacêutica oral de baixa dose seu processo de preparação e método de tratamento
BR112017026834A2 (pt) composição compreendendo vitaminas b e vitaminas c e seu uso
UA118474C2 (uk) (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
PH12018500772A1 (en) Bird feed and in particular poultry feed, comprising synthetic capsaicinoid derivatives and such feed for prohylactic use or treatment of salmonella infection
BR112017026013A2 (pt) sistema de distribuição oral, alginato de etilenodiamônio, grânulos de alginato de etilenodiamônio e alimentação funcional
CL2017001407A1 (es) Antagonista de a2a de dosis baja para el tratamiento de tdah y la enfermedad de parkinson
BR112017020404A2 (pt) medicamento
BR112017024732A2 (pt) combinação farmacêutica de everolimus com dactolisibe
BR112015024434A2 (pt) composição de luteína adequada para formulações de alimentos para crianças
BR112017008621A2 (pt) métodos e composições para promover a massa corporal magra, minimizar o ganho de gordura corporal e gerir o peso
BR112017022856A2 (pt) combinação de dose fixa inviolável que proporciona rápida liberação de duas drogas a partir de partículas
WO2016072692A3 (ko) 네크록스를 유효성분으로 함유하는 점막염 예방 또는 치료용 조성물
BR112017007863A2 (pt) composição para o tratamento de condições envolvendo dor muscular
BR112017001963A2 (pt) composição farmacêutica oral, seu processo de preparação e método de tratamento
BR112018002257A2 (pt) composição, e nutracêutico, dispositivo de uso médico, suplemento alimentar ou alimento de uso médico a

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/06/2016, OBSERVADAS AS CONDICOES LEGAIS